Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical Trial Data Release: Be Careful What You Wish For, Industry Exec Says

Executive Summary

Some advocates and researchers say that data availability could inform repurposing opportunities for products, but a GSK exec cautions that it could just as easily bring a flood of confusing information.


Related Content

Keytruda's New Tissue-Agnostic Indication Could Prompt Orphan Policy Changes
NIH Translational Science Center Gets Expanded Powers In Cures Bill
Clinical Data Sharing Could Increase Research Costs, Industry Fears
Sponsors Might Share Research Committees As Pressure Mounts To Share Data
GSK Champions More Trial Data Disclosure, But PhRMA Objects
NIH Drug Repurposing Program Produces Surprise Overlaps
Glaxo Opens Its Clinical Trial Library To Encourage Drug Development Compliance: Absent Regs, Enforcement Of Reporting Still Lags
Lilly In Collaboration To Screen NIH Pharmaceuticals Collection, Make Pharmacology Data Public


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts